SARS-CoV-2 and amyloid beta peptide: an unhealthy duo
Victoria Belen Ayala-Peña
Departamento de Biología, Bioquímica y Farmacia, Universidad Nacional
del Sur-CONICET, 8000 Bahía Blanca, Buenos Aires, Argentina
vayala@criba.edu.ar
Abstract: The volume of knowledge that the scientific community
has compiled about SARS-CoV-2 and amyloid beta peptide is scarce, but it
is growing every day. The interaction between the virus and the amyloid
beta peptide is poorly understood and some data are unclear. The
long-term consequences of SARS-CoV-2 infection on human health remain
uncertain at this time. The present work provides a discussion about the
association between the amyloid beta peptide and COVID-19.
Keywords : Spike, beta amyloid peptide, alzheimer, SARS-CoV-2,
ACE2